Active Filter(s):
Details:
The trial did not meet the primary endpoint of progression- free survival vs. platinum-based chemotherapy.
Lead Product(s): Cediranib,Olaparib
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Phase III Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 12, 2020